MMC
46
5
AAL
56
5
EMR
57
7
SRE
37
9
IPG
43
3
XYL
29
4
AAP
26
5
LB
16
9
JBHT
46
4
PBI
30
-8
OI
23
3
GS
65
16
SLG
37
6
CVX
25
14
T
32
2
LEN
21
3
BAC
38
3
CA
19
6
NI
63
5
BIIB
36
8
MMC
46
5
AAL
56
5
EMR
57
7
SRE
37
9
IPG
43
3
XYL
29
4
AAP
26
5
LB
16
9
JBHT
46
4
PBI
30
-8
OI
23
3
GS
65
16
SLG
37
6
CVX
25
14
T
32
2
LEN
21
3
BAC
38
3
CA
19
6
NI
63
5
BIIB
36
8
Financhill
Back

Achieve Life Sciences 10K Form

Sell
25

ACHV
Achieve Life Sciences

Last Price:
$3.69
Seasonality Move:
16.1%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ACHV News And Ratings

See the #1 stock for the next 7 days that we like better than ACHV

ACHV Financial Statistics

Sales & Book Value

Annual Sales: $5.1M
Cash Flow: $-10.4M
Price / Cash Flow: 0
Annual Sales: $0.91
Price / Book: 4.06

Profitability

EPS (TTM): -1.11000
Net Income (TTM): $-32.9M
Gross Margin: $29.9M
Return on Equity: 0%
Return on Assets: 0%

Achieve Life Sciences Earnings Forecast

Key Achieve Life Sciences Financial Ratios

  • The Gross Profit Margin over the past 17 years for ACHV is 99.99%.
  • The Selling, General & Administrative Expenses for ACHV have been equal to 28.22% of Gross Profit Margin.
  • The Interest Expense is -9.57% of Operating Income.
  • Per Share Earnings over the last 30 years have been positive in 20 years.

Achieve Life Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ACHV
CUSIP: 004468
Website: achievelifesciences.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ACHV Technical Analysis vs Fundamental Analysis

Sell
25
Achieve Life Sciences (ACHV) is a Sell

Is Achieve Life Sciences a Buy or a Sell?